Sarepta Therapeutics (SRPT) Inventory (2016 - 2026)

Sarepta Therapeutics' Inventory history runs 11 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Inventory rose 6.34% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 6.34% YoY), while the FY2025 annual figure was $914.7 million, up 21.97% from the prior year.
• Inventory for Q1 2026 stood at $1.0 billion, up from $914.7 million in the prior quarter.
• The five-year high for Inventory was $1.1 billion in Q3 2025, with the low at $199.0 million in Q1 2022.
• The 5-year median for Inventory is $373.5 million (2024), against an average of $525.4 million.
• The sharpest annual moves came in 2022 and 2025: Inventory fell 23.32% in 2022, then jumped 152.04% in 2025.
• Sarepta Therapeutics' Inventory stood at $204.0 million in 2022, then jumped by 58.29% to $322.9 million in 2023, then soared by 132.29% to $750.0 million in 2024, then grew by 21.97% to $914.7 million in 2025, then advanced by 9.44% to $1.0 billion in 2026.
• Business Quant data shows SRPT's Inventory at $1.0 billion in Q1 2026, $914.7 million in Q4 2025, and $1.1 billion in Q3 2025.